Increased use of cross-sectional imaging for follow-up does not improve post-recurrence survival of surgically treated initially localized R.C.C.: results from a European multicenter database (R.E.C.U.R.)

References

• Brandenbarg D, Berendsen AJ, de Bock GH. Patients' expectations and preferences regarding cancer follow-up care. Maturitas. 2017;105:58–63.
   PubMed Web of Science ®Google Scholar
• NCCN Clinical Practise Guidelines in Oncology (NCCN Guidelines): Kidney Cancer [www.nccn.org]
   Google Scholar
• The European Association of Urology (EAU) Renal Cell Cancer Guidelines, 2018 edition [http://uroweb.org/guideline/renal-cell-carcinoma/]
   Google Scholar
• Follow-up for Clinically Localized Renal Neoplasms [www.auanet.org]
   Google Scholar
• Sandock DS, Seftel AD, Resnick MI. A new protocol for the followup of renal cell carcinoma based on pathological stage. J Urol. 1995;154:28–31.
   PubMed Web of Science ®Google Scholar
• Levy DA, Slaton JW, Swanson DA, et al. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol. 1998;159:1163–1167.
   PubMed Web of Science ®Google Scholar
• Stephenson AJ, Chetner MP, Rourke K, et al. Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy. J Urol. 2004;172:58–62.
   PubMed Web of Science ®Google Scholar
• Klatte T, Lam JS, Shuch B, et al. Surveillance for renal cell carcinoma: why and how? When and how often? Urol Oncol. 2008;26:550–554.
   PubMed Web of Science ®Google Scholar
• Lam JS, Shvarts O, Leppert JT, et al. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. J Urol. 2005;174:466–472. discussion 472; quiz 801.
   PubMed Web of Science ®Google Scholar
• Skolarikos A, Alivizatos G, Laguna P, et al. A review on follow-up strategies for renal cell carcinoma after nephrectomy. Eur Urol. 2007;51:1490–discussion 1501.
   PubMed Web of Science ®Google Scholar
• Siddiqui SA, Frank I, Cheville JC, et al. Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol. BJU Int. 2009;104:778–785.
   PubMed Web of Science ®Google Scholar
• Dabestani S, Beisland C, Stewart GD, et al. Intensive imaging-based follow-up of surgically treated localised renal cell carcinoma does not improve post-recurrence survival: Results from a European Multicentre Database (RECUR). Eur Urol. 2019;75:261–264.
   PubMed Web of Science ®Google Scholar
• Kim EH, Vetter JM, Kuxhausen AN, et al. Limited use of surveillance imaging following nephrectomy for renal cell carcinoma. Urol Oncol. 2016;34:237 e211–238.
   Web of Science ®Google Scholar
• Mouracade P, Chavali JS, Kara O, et al. Imaging strategy and outcome following partial nephrectomy. Urol Oncol. 2017;35:660.e1–660.e8.
   PubMed Web of Science ®Google Scholar
• Feuerstein MA, Atoria CL, Pinheiro LC, et al. Patterns of surveillance imaging after nephrectomy in the Medicare population. BJU Int. 2016;117:280–286.
   PubMed Web of Science ®Google Scholar
• Leibovich BC, Blute ML, Cheville JC, et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer. 2003;97:1663–1671.
   PubMed Web of Science ®Google Scholar
• Beisland C, Gudbrandsdottir G, Reisaeter LAR, et al. Contemporary external validation of the Leibovich model for prediction of progression after radical surgery for clear cell renal cell carcinoma. Scand J Urol. 2015;49:205–210.
   PubMed Web of Science ®Google Scholar
• Zisman A, Pantuck AJ, Dorey F, et al. Improved prognostication of renal cell carcinoma using an integrated staging system. JCO. 2001;19:1649–1657.
   PubMed Web of Science ®Google Scholar
• Dabestani S, Beisland C, Stewart GD, et al. Long-term outcomes of follow-up for initially localised clear cell renal cell carcinoma: RECUR database analysis. Eur Urol Focus. 2018. doi:10.1016/j.euf.2018.02.010.
   PubMedGoogle Scholar
• Sosa MS, Bragado P, Aguirre-Ghiso JA. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer. 2014;14:611–622.
   PubMed Web of Science ®Google Scholar
• Turajlic S, Xu H, Litchfield K, et al. Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal. Cell. 2018;173:581–594. e512
   PubMed Web of Science ®Google Scholar
• Turajlic S, Swanton C. Metastasis as an evolutionary process. Science. 2016;352:169–175.
   PubMed Web of Science ®Google Scholar
• Dillekas H, Demicheli R, Ardoino I, et al. The recurrence pattern following delayed breast reconstruction after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases. Breast Cancer Res Treat. 2016;158:169–178.
   PubMed Web of Science ®Google Scholar
• Dillekas H, Transeth M, Pilskog M, et al. Differences in metastatic patterns in relation to time between primary surgery and first relapse from breast cancer suggest synchronized growth of dormant micrometastases. Breast Cancer Res Treat. 2014;146:627–636.
   PubMed Web of Science ®Google Scholar
• Beisland C, Guðbrandsdottir G, Reisaeter LAR, et al. A prospective risk-stratified follow-up programme for radically treated renal cell carcinoma patients: evaluation after eight years of clinical use. World J Urol. 2016;34:1087–1099.
   PubMed Web of Science ®Google Scholar
• Merrill SB, Sohl BS, Hamirani A, et al. Capturing renal cell carcinoma recurrences when asymptomatic improves patient survival. Clin Genitourin Cancer. 2018. doi:10.1016/j.clgc.2018.11.009.
   PubMed Web of Science ®Google Scholar
• Doornweerd BH, de Jong IJ, Bergman LM, et al. Chest X-ray in the follow-up of renal cell carcinoma. World J Urol. 2014;32:1015–1019.
   PubMed Web of Science ®Google Scholar
• Dai J, Lu Y, Wang J, et al. A four-gene signature predicts survival in clear-cell renal-cell carcinoma. Oncotarget. 2016;7:82712–82726.
   PubMedGoogle Scholar
• Brooks SA, Brannon AR, Parker JS, et al. ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014;66:77–84.
   PubMed Web of Science ®Google Scholar
• Brannon AR, Reddy A, Seiler M, et al. Molecular stratification of clear cell renal cell carcinoma by consensus clustering reveals distinct subtypes and survival patterns. Genes Cancer. 2010;1:152–163.
   PubMedGoogle Scholar
• Stewart-Merrill SB, Thompson RH, Boorjian SA, et al. Oncologic surveillance after surgical resection for renal cell carcinoma: a novel risk-based approach. J Clin Oncol. 2015;33:4151–4157.
   PubMed Web of Science ®Google Scholar
• Merrill SB. More isn't always better: time to derive a different strategy for renal cell carcinoma surveillance. Eur Urol. 2019;75:265–267.
   PubMed Web of Science ®Google Scholar